RPA3 reportedly acts by forming an RPA complex with RPA1 and RPA2 8, but the RPA1 and RPA2 expression levels did not significantly differ between radioresistant NPC, radiosensitive NPC and normal samples (Fig. 1A and B). Here, RPA3 is linked to nasopharyngeal carcinoma.